What to Know about Universal Proxy with Bruce Goldfarb of Okapi Partners

by | Sep 12, 2022

Okapi’s Bruce Goldfarb joins the podcast to discuss the new Universal Proxy Rules

On August 31 the SEC adopted the widely anticipated “Universal Proxy Rules” and now, going forward, all contested director election processes will have to follow the new rules.

What’s Changing?

Both management and the dissident slates of directors in a contested situation will now be on one proxy card, thereby allowing shareholders to vote on individual directors, rather than the entire slate of one side. This will enable investors to mix and match their director selections.

We sat down with Okapi Partners CEO Bruce Goldfarb to break down the rules, changes, and the implications for companies, board members, and shareholders alike. Will corporate activism campaigns start to resemble political campaigns? Have a listen.

Topics Discussed

  • How we got here and overview of changes
  • Will universal proxy leads to more activism?
  • What it means for individual directors
  • Any ESG or DEI implications
  • Winners and losers

About Bruce Goldfarb

Bruce H. Goldfarb is President and Chief Executive Officer of Okapi Partners, the proxy solicitation and investor response firm.  Bruce works extensively with corporations and investors focusing on investor response strategy and execution for contested election campaigns, mergers and acquisitions, corporate governance matters, ESG engagement and other extraordinary situations.

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

More Know Who Drives Return Podcast Episodes

Latest Boardroom Alpha Research

SPAC Daily: Court Battles Heat Up

CPTK and FST are set up for court battles related to their failed business combinations, and the rest of the day’s SPAC news.

SPAC Daily: Terminations on the Rise

SPAC Market Review – July 2022Full SPAC ListingPodcast: Know Who Drives ReturnDaily SPAC Newsletter Call it the dog days of SPAC summer, as August has been nasty for pending SPAC mergers. No surprise that mergers are facing tons of obstacles today from the lack of...

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.